{
    "title": "U.S. FDA to review Emergent's OTC opioid overdose drug on priority",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11509127/U-S-FDA-review-Emergents-OTC-opioid-overdose-drug-priority.html",
    "date": "2022-12-06",
    "keywords": [
        "drug",
        "use",
        "emergent",
        "overdose",
        "overthecounter",
        "nasal",
        "spray",
        "treatment",
        "priority",
        "health",
        "regulator",
        "country",
        "review",
        "analyst",
        "naloxone",
        "risk",
        "peaker",
        "dec",
        "contract",
        "drugmaker",
        "tuesday",
        "opioid",
        "basis",
        "food",
        "approval",
        "sale",
        "agency",
        "decision",
        "march",
        "status",
        "track",
        "counter",
        "benchmark",
        "robert",
        "announcement",
        "fda",
        "way",
        "access",
        "crisis",
        "president",
        "joe",
        "administration",
        "narcan",
        "competition",
        "pressuring",
        "cowen",
        "boris",
        "nalmafene",
        "protection",
        "government",
        "increase",
        "year",
        "company",
        "application",
        "usability",
        "bhanvi",
        "satija",
        "khushi",
        "mandowara",
        "bengaluru",
        "editing",
        "anil",
        "dsilva",
        "maju",
        "samuel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}